| 发明名称 |
MORPHOGEN TREATMENT FOR CHRONIC RENAL FAILURE |
| 摘要 |
<p>The present invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of chronic renal failure, or at risk of a need for renal replacement therapy. The methods involve the administration of certain proteins of, or based upon, the osteogenic protein/bone morphogenetic protein (OP/BMP) family within the TGF-beta superfamily of proteins.</p> |
| 申请公布号 |
EP0914146(B1) |
申请公布日期 |
2004.09.29 |
| 申请号 |
EP19970922726 |
申请日期 |
1997.05.06 |
| 申请人 |
CURIS, INC. |
发明人 |
SAMPATH, KUBER, T.;COHEN, CHARLES, M.;VUKICEVIC, SLOBODAN |
| 分类号 |
A61K38/00;A61K31/00;A61K38/18;A61K38/27;A61K45/00;A61P3/00;A61P3/10;A61P9/00;A61P9/12;A61P13/00;A61P13/12;C07K14/51;(IPC1-7):A61K38/18 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
